Top 10 Biotechnology Angel Investors in Italy in February 2025

Last updated: Feb 2025 A list of 10 angel investors that invest in Biotechnology startups based in Italy. We rank investors based on the number of investments they made in Biotechnology companies from Italy. We update this investor list every month.

Top 10 Biotechnology Angel Investors in Italy in February 2025

Investor	Biotechnology Italy investments
Barbara Castellano	2
Hermann Hauser	1
Mauro Cogoli	1
Elena Paola Lanati	1
Harald Oberrauch	1
Stefano Bernardi	1
Enrico Pandian	1
Stefano De Rossi	1
Giovanni Zobele	1
Michael Gebert	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Laura Iris Ferro

Investment focus

Health Care, Biotechnology, Medical Device
Pre-Seed, Funding Round
Italy

Portfolio highlights

Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Hermann Hauser is the Co-founder, Director, and Venture Partner of Amadeus Capital Partners. He previously worked at IXI as a Founder. Hermann Hauser attended the University of Vienna.

Investment focus

Software, Information Technology, Machine Learning
Series A, Funding Round, Seed
United Kingdom, Austria, Italy

Portfolio highlights

Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
NXRT — Driving simulations for sales and training
Fractile — Fractile is building chips to run large language models two orders of magnitude faster. Existing hardware is good for training LLMs, but very poorly suited to subsequent inference of the trained model, which is increasingly the dominant workload. A network’s weights need to be moved onto a chip once per word generated, and this movement takes a fewhundred times longer than the subsequent computations themselves. Fractile’s revolutionary approach to fusing computation with memory eliminates this bottleneck, and can scale to allow running the world’s largest models at a global scale.

Mauro Cogoli

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Elena Paola Lanati

Investment focus

Biotechnology, Manufacturing, Nanotechnology
Seed
Italy

Portfolio highlights

Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.

Harald Oberrauch

Investment focus

Health Care, Biotechnology
Seed
Italy

Portfolio highlights

Immagina Biotechnology — Immagina BioTechnology is a StartUp hosted in the Laboratory for Biomolecular Sequence and Structure Analysis for Health (LaBSSAH), a hub comprising private and public institutions: the Bruno Kessler Foundation (FBK), the Institute of Biophysics of the Italian National Research Council (CNR-IBF) and the Centre for Integrative Biology of theUniversity of Trento (CIBIO). Immagina represents a unique opportunity to profitably match the academic know-how and industrial needs.

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Investment focus

Software, Biotechnology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
Italy, France, Norway

Portfolio highlights

Freatic — Building the monetization layer for your alpha
Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
CaSRevolution — A novel disease-modifying approach against neurodegeneration

Enrico Pandian is the Co-Founder and CEO of StartupGym and the Founder of FrescoFrigo. He previously worked at Checkout Technologies as a Co-Founder and President of the Board. Enrico Pandian attended the University of Verona.